Omkar Pharmachem Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported revenue was INR 1.39 million compared to INR 1.38 million a year ago. Net loss was INR 0.159 million compared to INR 0.084 million a year ago. Basic loss per share from continuing operations was INR 0.0158 compared to INR 0.0083 a year ago. Diluted loss per share from continuing operations was INR 0.0158 compared to INR 0.0083 a year ago.
For the full year, revenue was INR 5.44 million compared to INR 5.43 million a year ago. Net income was INR 1.89 million compared to INR 1.98 million a year ago. Basic earnings per share from continuing operations was INR 0.1875 compared to INR 0.1962 a year ago. Diluted earnings per share from continuing operations was INR 0.1875 compared to INR 0.1962 a year ago.